2016 Q4 Form 10-K Financial Statement
#000117184317001747 Filed on March 24, 2017
Income Statement
Concept | 2016 Q4 | 2016 | 2015 Q4 |
---|---|---|---|
Revenue | $509.0K | $3.477M | $660.0K |
YoY Change | -22.88% | -39.06% | 1.54% |
Cost Of Revenue | $2.548M | $460.0K | |
YoY Change | 3.07% | -49.45% | |
Gross Profit | $929.0K | $200.0K | |
YoY Change | -71.27% | -176.92% | |
Gross Profit Margin | 26.72% | 30.3% | |
Selling, General & Admin | $2.520M | $8.441M | $2.700M |
YoY Change | -6.67% | -17.66% | 37.76% |
% of Gross Profit | 908.61% | 1350.0% | |
Research & Development | $3.906M | $13.69M | $460.0K |
YoY Change | 749.13% | 1266.47% | 228.57% |
% of Gross Profit | 1473.84% | 230.0% | |
Depreciation & Amortization | $200.0K | $300.0K | $40.00K |
YoY Change | 400.0% | 63.04% | 33.33% |
% of Gross Profit | 32.29% | 20.0% | |
Operating Expenses | $3.906M | $20.46M | $3.160M |
YoY Change | 23.61% | 49.1% | 50.48% |
Operating Profit | -$16.99M | -$2.960M | |
YoY Change | 51.85% | 25.42% | |
Interest Expense | -$60.00K | $95.00K | -$20.00K |
YoY Change | 200.0% | -32.62% | |
% of Operating Profit | |||
Other Income/Expense, Net | -$60.00K | $39.00K | |
YoY Change | -72.34% | ||
Pretax Income | -$5.970M | -$17.27M | -$2.980M |
YoY Change | 100.34% | 52.43% | 31.86% |
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$5.974M | -$17.27M | -$2.980M |
YoY Change | 100.47% | 52.49% | 31.86% |
Net Earnings / Revenue | -1173.67% | -496.81% | -451.52% |
Basic Earnings Per Share | |||
Diluted Earnings Per Share | -$149.3M | -$431.8M | -$59.60M |
COMMON SHARES | |||
Basic Shares Outstanding | 10.64M | ||
Diluted Shares Outstanding |
Balance Sheet
Concept | 2016 Q4 | 2016 | 2015 Q4 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $22.10M | $22.10M | $10.80M |
YoY Change | 104.63% | 104.63% | 111.76% |
Cash & Equivalents | $22.10M | $22.10M | $21.24M |
Short-Term Investments | |||
Other Short-Term Assets | $1.800M | $1.800M | $300.0K |
YoY Change | 500.0% | 500.0% | -25.0% |
Inventory | $64.00K | $187.0K | |
Prepaid Expenses | |||
Receivables | $20.00K | $0.00 | $394.0K |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $23.88M | $23.90M | $11.73M |
YoY Change | 103.49% | 104.27% | 72.94% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $625.0K | $600.0K | $1.153M |
YoY Change | -45.79% | -50.0% | -5.02% |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $258.0K | $300.0K | $0.00 |
YoY Change | -100.0% | ||
Total Long-Term Assets | $883.0K | $900.0K | $1.168M |
YoY Change | -24.4% | -25.0% | -10.43% |
TOTAL ASSETS | |||
Total Short-Term Assets | $23.88M | $23.90M | $11.73M |
Total Long-Term Assets | $883.0K | $900.0K | $1.168M |
Total Assets | $24.76M | $24.80M | $12.90M |
YoY Change | 91.91% | 92.25% | 59.5% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $1.007M | $1.000M | $242.0K |
YoY Change | 316.12% | 400.0% | -5.1% |
Accrued Expenses | $3.909M | $3.900M | $1.018M |
YoY Change | 283.99% | 333.33% | 181.99% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $1.100M |
YoY Change | -100.0% | -100.0% | |
Long-Term Debt Due | $2.000M | $2.000M | $0.00 |
YoY Change | -100.0% | ||
Total Short-Term Liabilities | $6.885M | $6.900M | $2.468M |
YoY Change | 178.97% | 176.0% | 24.08% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $2.800M | $2.800M | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | $0.00 | $0.00 | $24.00K |
YoY Change | -100.0% | -77.98% | |
Total Long-Term Liabilities | $0.00 | $2.800M | $24.00K |
YoY Change | -100.0% | -77.98% | |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $6.885M | $6.900M | $2.468M |
Total Long-Term Liabilities | $0.00 | $2.800M | $24.00K |
Total Liabilities | $9.705M | $9.700M | $2.492M |
YoY Change | 289.45% | 288.0% | 18.78% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$67.08M | -$17.97M | |
YoY Change | 273.31% | 170.6% | |
Common Stock | $8.000K | $7.000K | |
YoY Change | 14.29% | -81.58% | |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$61.92M | $15.10M | -$45.29M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $24.76M | $24.80M | $12.90M |
YoY Change | 91.91% | 92.25% | 59.5% |
Cashflow Statement
Concept | 2016 Q4 | 2016 | 2015 Q4 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$5.974M | -$17.27M | -$2.980M |
YoY Change | 100.47% | 52.49% | 31.86% |
Depreciation, Depletion And Amortization | $200.0K | $300.0K | $40.00K |
YoY Change | 400.0% | 63.04% | 33.33% |
Cash From Operating Activities | -$9.410M | -$14.76M | -$1.300M |
YoY Change | 623.85% | 113.9% | 31.31% |
INVESTING ACTIVITIES | |||
Capital Expenditures | -$250.0K | $250.0K | -$20.00K |
YoY Change | 1150.0% | 103.25% | -92.59% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $0.00 | $0.00 | $0.00 |
YoY Change | -100.0% | ||
Cash From Investing Activities | -$250.0K | -$250.0K | -$30.00K |
YoY Change | 733.33% | 163.16% | -88.46% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | $2.000K | ||
YoY Change | -100.02% | ||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 15.99M | $15.87M | 30.00K |
YoY Change | 53200.0% | 24.93% | -400.0% |
NET CHANGE | |||
Cash From Operating Activities | -9.410M | -$14.76M | -1.300M |
Cash From Investing Activities | -250.0K | -$250.0K | -30.00K |
Cash From Financing Activities | 15.99M | $15.87M | 30.00K |
Net Change In Cash | 6.330M | $869.0K | -1.300M |
YoY Change | -586.92% | -84.79% | 3.17% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$9.410M | -$14.76M | -$1.300M |
Capital Expenditures | -$250.0K | $250.0K | -$20.00K |
Free Cash Flow | -$9.160M | -$15.01M | -$1.280M |
YoY Change | 615.63% | 113.72% | 77.78% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2016 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
797000 | |
CY2016 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
53715 | |
CY2015 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
64449 | |
CY2015 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
||
CY2016Q4 | us-gaap |
Assets
Assets
|
4259000 | |
CY2016Q4 | mgen |
Accrued Contract Research And Development
AccruedContractResearchAndDevelopment
|
203000 | |
CY2015Q4 | mgen |
Accrued Contract Research And Development
AccruedContractResearchAndDevelopment
|
35000 | |
CY2016Q4 | mgen |
Capital Lease Obligation Unamortized Discount
CapitalLeaseObligationUnamortizedDiscount
|
3000 | |
CY2015Q4 | mgen |
Capital Lease Obligation Unamortized Discount
CapitalLeaseObligationUnamortizedDiscount
|
6000 | |
CY2016Q4 | mgen |
Capital Lease Obligations Monthly Rent
CapitalLeaseObligationsMonthlyRent
|
7200 | |
CY2016Q4 | mgen |
Contractual Allowance
ContractualAllowance
|
3200000 | |
CY2015Q4 | mgen |
Contractual Allowance
ContractualAllowance
|
2100000 | |
CY2016 | mgen |
Contractual Allowances
ContractualAllowances
|
5313000 | |
CY2015 | mgen |
Contractual Allowances
ContractualAllowances
|
3168000 | |
CY2016 | mgen |
Contractual Allowances Percentage
ContractualAllowancesPercentage
|
0.61 | |
CY2015 | mgen |
Contractual Allowances Percentage
ContractualAllowancesPercentage
|
0.56 | |
CY2016 | mgen |
Effective Income Tax Rate Reconciliation Credits And Other Adjustments
EffectiveIncomeTaxRateReconciliationCreditsAndOtherAdjustments
|
331000 | |
CY2015 | mgen |
Effective Income Tax Rate Reconciliation Credits And Other Adjustments
EffectiveIncomeTaxRateReconciliationCreditsAndOtherAdjustments
|
-42000 | |
CY2016 | mgen |
Increase Decrease In Lease Termination Abandonment Payable
IncreaseDecreaseInLeaseTerminationAbandonmentPayable
|
||
CY2015 | mgen |
Increase Decrease In Lease Termination Abandonment Payable
IncreaseDecreaseInLeaseTerminationAbandonmentPayable
|
248000 | |
CY2016 | mgen |
Sales Revenue Gross
SalesRevenueGross
|
8650000 | |
CY2015 | mgen |
Sales Revenue Gross
SalesRevenueGross
|
5706000 | |
CY2016Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
159000 | |
CY2015Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
242000 | |
CY2016Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
524000 | |
CY2015Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
394000 | |
CY2016Q4 | us-gaap |
Accrued Bonuses Current
AccruedBonusesCurrent
|
860000 | |
CY2015Q4 | us-gaap |
Accrued Bonuses Current
AccruedBonusesCurrent
|
592000 | |
CY2016Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
3377000 | |
CY2015Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
1018000 | |
CY2015Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
739000 | |
CY2016Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
30309000 | |
CY2015Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
28371000 | |
CY2015Q1 | us-gaap |
Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
|
8700000 | |
CY2015 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
3015000 | |
CY2016 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
2111000 | |
CY2016 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
2111000 | |
CY2015 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
3015000 | |
CY2016Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
54000 | |
CY2015Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
0 | |
CY2015 | us-gaap |
Cash Period Increase Decrease
CashPeriodIncreaseDecrease
|
5713000 | |
CY2016Q4 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
80.70 | |
CY2015Q1 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
52.50 | |
CY2015Q1 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
10707 | |
CY2016Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
13534 | |
CY2015Q4 | us-gaap |
Assets
Assets
|
12902000 | |
CY2016Q4 | us-gaap |
Assets Current
AssetsCurrent
|
4259000 | |
CY2015Q4 | us-gaap |
Assets Current
AssetsCurrent
|
11734000 | |
CY2016Q4 | us-gaap |
Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
|
170000 | |
CY2015Q4 | us-gaap |
Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
|
||
CY2016 | us-gaap |
Business Exit Costs1
BusinessExitCosts1
|
2037000 | |
CY2015 | us-gaap |
Business Exit Costs1
BusinessExitCosts1
|
||
CY2016Q4 | us-gaap |
Capital Lease Obligations
CapitalLeaseObligations
|
4000 | |
CY2015Q4 | us-gaap |
Capital Lease Obligations
CapitalLeaseObligations
|
88000 | |
CY2016Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
3341000 | |
CY2015Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
10832000 | |
CY2014Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
5119000 | |
CY2016 | us-gaap |
Cash Period Increase Decrease
CashPeriodIncreaseDecrease
|
-7491000 | |
CY2016Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2015Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2016Q4 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
118694 | |
CY2016Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2015Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2016Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
50000000 | |
CY2015Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
50000000 | |
CY2016Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
742293 | |
CY2015Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
709024 | |
CY2016Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
742293 | |
CY2015Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
709024 | |
CY2016Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
7000 | |
CY2015Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
7000 | |
CY2016 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Concentration of Credit Risk, Major Customers and Suppliers</div></div></div> <div style=" font-size: 10pt; margin: 0pt 0"> </div> <div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Financial instruments that potentially subject Signal to concentrations of credit risk are primarily cash and cash equivalents. Cash is maintained at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> financial institutions and, at times, balances <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> exceed federally insured limits. Signal has not experienced any losses related to these balances. Signal invests excess cash in money market funds under the custodianship of a major financial institution. This diversification of risk is consistent with Signal’s policy to ensure safety of principal and maintain liquidity.</div> <div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"> </div> <div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">During the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> Signal had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> major customers, including UAMS. Revenue sourced either from or through UAMS accounted for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">22%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">54%</div> of net revenue during the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> respectively. Revenue sourced either from or through Mount Sinai Hospital as a percentage of net revenue during the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> accounted for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">24%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%,</div> respectively. Revenue sourced either from or through Moffitt Cancer Center as a percentage of net revenue during the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> accounted for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9%,</div> respectively.</div> <div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"> </div> <div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Accounts receivable from UAMS as a percentage of total accounts receivable as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19%,</div> respectively. Signal had no accounts receivable from the other <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> major customers since revenue sourced through them is billed to various <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">third</div>-party payors, depending on a patient’s medical insurance policy.</div> <div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0"> </div> <div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">Inventory used in Signal’s testing process is procured from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> supplier. Any supply interruption or an increase in demand beyond such supplier’s capabilities could have an adverse impact on Signal’s business. Management believes it could identify alternative suppliers, if necessary, but it is possible such suppliers <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> not be identified in a timely manner to avoid an adverse impact on Signal’s business.</div></div></div> | |
CY2016 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
2548000 | |
CY2015 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
2472000 | |
CY2016 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
15845000 | |
CY2015 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
13725000 | |
CY2016Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
7792000 | |
CY2015Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
5046000 | |
CY2016Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
||
CY2015Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
||
CY2016Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
10000 | |
CY2015Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
350000 | |
CY2016Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
6883000 | |
CY2015Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
3913000 | |
CY2016Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
52000 | |
CY2015Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
||
CY2016Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
|
98000 | |
CY2015Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
|
52000 | |
CY2016Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
|
505000 | |
CY2015Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
|
257000 | |
CY2016Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
205000 | |
CY2015Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
810000 | |
CY2016Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
|
49000 | |
CY2015Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
|
14000 | |
CY2016Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
7782000 | |
CY2015Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
4696000 | |
CY2016Q4 | us-gaap |
Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
|
10000 | |
CY2015Q4 | us-gaap |
Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
|
350000 | |
CY2016 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
189000 | |
CY2015 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
184000 | |
CY2016 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-17.58 | |
CY2015 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-21.02 | |
CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.34 | |
CY2015 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.34 | |
CY2016Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
125000 | |
CY2015Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
234000 | |
CY2016 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-71000 | |
CY2015 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
||
CY2016 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
7906000 | |
CY2015 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
7692000 | |
CY2016 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
||
CY2015 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
||
CY2016 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
3086000 | |
CY2015 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
3625000 | |
CY2016 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
-4309000 | |
CY2015 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
-3851000 | |
CY2016 | us-gaap |
Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
|
364000 | |
CY2015 | us-gaap |
Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
|
19000 | |
CY2016 | us-gaap |
Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
|
721000 | |
CY2015 | us-gaap |
Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
|
526000 | |
CY2016 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
-193000 | |
CY2015 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
-277000 | |
CY2016 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
2028000 | |
CY2015 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
633000 | |
CY2016 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
130000 | |
CY2015 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-694000 | |
CY2015Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
2468000 | |
CY2016 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-257000 | |
CY2015 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
12706000 | |
CY2016 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-3000 | |
CY2015 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-95000 | |
CY2016 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-7231000 | |
CY2015 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-6898000 | |
CY2016 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-12674000 | |
CY2015 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-11328000 | |
CY2016 | us-gaap |
Increase Decrease In Deposits
IncreaseDecreaseInDeposits
|
||
CY2015 | us-gaap |
Increase Decrease In Deposits
IncreaseDecreaseInDeposits
|
28000 | |
CY2016 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-123000 | |
CY2015 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
8000 | |
CY2016 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-161000 | |
CY2015 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-28000 | |
CY2016 | us-gaap |
Interest Expense
InterestExpense
|
95000 | |
CY2015 | us-gaap |
Interest Expense
InterestExpense
|
141000 | |
CY2016 | us-gaap |
Interest Paid
InterestPaid
|
2000 | |
CY2015 | us-gaap |
Interest Paid
InterestPaid
|
6000 | |
CY2016Q4 | us-gaap |
Inventory Net
InventoryNet
|
64000 | |
CY2015Q4 | us-gaap |
Inventory Net
InventoryNet
|
187000 | |
CY2015Q1 | us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
198000 | |
CY2015 | us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
330000 | |
CY2016Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
4259000 | |
CY2015Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
12902000 | |
CY2016Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
4585000 | |
CY2016Q4 | us-gaap |
Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
|
1045000 | |
CY2015Q4 | us-gaap |
Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
|
1105000 | |
CY2016 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-12508000 | |
CY2015 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-11187000 | |
CY2016 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
240000 | |
CY2015 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
234000 | |
CY2016Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
148000 | |
CY2015Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
84000 | |
CY2016 | us-gaap |
Other Expenses
OtherExpenses
|
166000 | |
CY2015 | us-gaap |
Other Expenses
OtherExpenses
|
141000 | |
CY2016Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
4000 | |
CY2015Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
103000 | |
CY2016Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
||
CY2015Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
24000 | |
CY2016 | us-gaap |
Paid In Kind Interest
PaidInKindInterest
|
93000 | |
CY2015 | us-gaap |
Paid In Kind Interest
PaidInKindInterest
|
132000 | |
CY2016 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
2000 | |
CY2015 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
||
CY2016 | us-gaap |
Payments For Restructuring
PaymentsForRestructuring
|
292000 | |
CY2015Q1 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
1200000 | |
CY2016 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
171000 | |
CY2015 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
363000 | |
CY2016 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
3000 | |
CY2015 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
123000 | |
CY2016Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
CY2015Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
CY2016Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | |
CY2015Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | |
CY2016Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2015Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2016Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2015Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2016Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
CY2015Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
CY2016Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
160000 | |
CY2015Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
321000 | |
CY2015Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
7800000 | |
CY2016 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
||
CY2015 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
13095000 | |
CY2016 | us-gaap |
Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
|
||
CY2015 | us-gaap |
Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
|
50000 | |
CY2015Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
1892000 | |
CY2015Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
1153000 | |
CY2016Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
||
CY2016 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
74000 | |
CY2015 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
33000 | |
CY2016 | us-gaap |
Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
|
84000 | |
CY2015 | us-gaap |
Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
|
76000 | |
CY2016 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
888000 | |
CY2015 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1002000 | |
CY2015 | us-gaap |
Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
|
-363000 | |
CY2016 | us-gaap |
Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
|
-171000 | |
CY2016Q4 | us-gaap |
Restructuring Reserve
RestructuringReserve
|
1745000 | |
CY2016Q4 | us-gaap |
Restructuring Reserve Current
RestructuringReserveCurrent
|
1745000 | |
CY2015Q4 | us-gaap |
Restructuring Reserve Current
RestructuringReserveCurrent
|
||
CY2016Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-30642000 | |
CY2015Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-17968000 | |
CY2016 | us-gaap |
Royalty Expense
RoyaltyExpense
|
86000 | |
CY2015 | us-gaap |
Royalty Expense
RoyaltyExpense
|
30000 | |
CY2016Q4 | us-gaap |
Royalty Guarantees Commitments Amount
RoyaltyGuaranteesCommitmentsAmount
|
30000 | |
CY2016 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
3337000 | |
CY2015 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
2538000 | |
CY2016Q4 | us-gaap |
Security Deposit
SecurityDeposit
|
||
CY2015Q4 | us-gaap |
Security Deposit
SecurityDeposit
|
15000 | |
CY2016 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
1669000 | |
CY2015 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
2559000 | |
CY2016 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2111000 | |
CY2015 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
3015000 | |
CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
|
67695 | |
CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
37465 | |
CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
28.83 | |
CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
10425 | |
CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
5786 | |
CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
37465 | |
CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
42104 | |
CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
34.20 | |
CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
28.83 | |
CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
37465 | |
CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
28.83 | |
CY2016 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
38.83 | |
CY2016 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
7.71 | |
CY2015Q1 | us-gaap |
Share Price
SharePrice
|
42 | |
CY2016 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P8Y219D | |
CY2016 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P8Y219D | |
CY2016 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P8Y219D | |
CY2015Q1 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
214286 | |
CY2015 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
12765000 | |
CY2016 | us-gaap |
Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
|
2000 | |
CY2016Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-326000 | |
CY2015Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
10410000 | |
CY2014Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
5991000 | |
CY2016 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Use of Estimates</div></div></div> <div style=" font-size: 10pt; margin: 0pt 0"> </div> <div style=" font-size: 10pt; text-indent: 0.25in; margin: 0pt 0">The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). The preparation of financial statements in conformity with GAAP requires management to make judgments, assumptions and estimates that affect the amounts reported in Signal’s financial statements and accompanying notes. Significant estimates in the financial statements have been made for revenue, accounts receivable and allowance for doubtful accounts, accounting for income taxes, depreciation of property and equipment and stock-based compensation. Actual results could differ materially from those estimates.</div></div></div> | |
CY2016 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
721415 | |
CY2015 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
539460 |